Silicon Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Silicon Laboratories has a total shareholder equity of $1.1B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.2B and $167.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$369.68m |
| Equity | US$1.08b |
| Total liabilities | US$167.86m |
| Total assets | US$1.25b |
Recent financial health updates
Health Check: How Prudently Does Silicon Laboratories (NASDAQ:SLAB) Use Debt?
Feb 19
Is Silicon Laboratories (NASDAQ:SLAB) A Risky Investment?
Nov 02Here's Why Silicon Laboratories (NASDAQ:SLAB) Can Manage Its Debt Responsibly
Jul 10Is Silicon Laboratories (NASDAQ:SLAB) Using Too Much Debt?
Apr 10Silicon Laboratories (NASDAQ:SLAB) Seems To Use Debt Quite Sensibly
Dec 19Recent updates
Investors Appear Satisfied With Silicon Laboratories Inc.'s (NASDAQ:SLAB) Prospects As Shares Rocket 26%
Dec 20A Slower, More Stretched-Out Recovery Has Weighed On Silicon Labs
Nov 05Pinning Down Silicon Laboratories Inc.'s (NASDAQ:SLAB) P/S Is Difficult Right Now
Nov 01Silicon Laboratories: A Questionable Outlook Offsets Improving Results
Oct 17Silicon Laboratories: Equity Story Remains Very Attractive
Jul 31Silicon Labs Ready For The Next IoT-Fueled Run
Jul 14Investor Optimism Abounds Silicon Laboratories Inc. (NASDAQ:SLAB) But Growth Is Lacking
Jul 11Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Could Be 31% Below Their Intrinsic Value Estimate
Jun 20Silicon Laboratories: An Uncertain Recovery Outlook Continues To Linger
May 05We Think Some Shareholders May Hesitate To Increase Silicon Laboratories Inc.'s (NASDAQ:SLAB) CEO Compensation
Apr 13Silicon Laboratories Inc.'s (NASDAQ:SLAB) Business Is Trailing The Industry But Its Shares Aren't
Mar 26Health Check: How Prudently Does Silicon Laboratories (NASDAQ:SLAB) Use Debt?
Feb 19Silicon Laboratories: Upgrade To Neutral As Near-Term Bear Case Is In Focus
Feb 11Are Investors Undervaluing Silicon Laboratories Inc. (NASDAQ:SLAB) By 31%?
Feb 01Silicon Laboratories: Why The Stock Could Be Heading Lower
Jan 30At US$132, Is It Time To Put Silicon Laboratories Inc. (NASDAQ:SLAB) On Your Watch List?
Jan 02Silicon Laboratories Inc. (NASDAQ:SLAB) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Dec 18Is Silicon Laboratories (NASDAQ:SLAB) A Risky Investment?
Nov 02Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Sep 29A Look At The Fair Value Of Silicon Laboratories Inc. (NASDAQ:SLAB)
Sep 11Silicon Laboratories Inc. (NASDAQ:SLAB) Analysts Just Slashed This Year's Revenue Estimates By 11%
Aug 04Is Now The Time To Put Silicon Laboratories (NASDAQ:SLAB) On Your Watchlist?
Jul 28Here's Why Silicon Laboratories (NASDAQ:SLAB) Can Manage Its Debt Responsibly
Jul 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
May 29Is Silicon Laboratories (NASDAQ:SLAB) Using Too Much Debt?
Apr 10Is It Time To Consider Buying Silicon Laboratories Inc. (NASDAQ:SLAB)?
Feb 13Silicon Laboratories (NASDAQ:SLAB) Seems To Use Debt Quite Sensibly
Dec 19What Is Silicon Laboratories Inc.'s (NASDAQ:SLAB) Share Price Doing?
Oct 17Silicon Laboratories Is Nearing An Important Junction (Technical Analysis)
Sep 26An Intrinsic Calculation For Silicon Laboratories Inc. (NASDAQ:SLAB) Suggests It's 27% Undervalued
Sep 26Financial Position Analysis
Short Term Liabilities: SLAB's short term assets ($614.1M) exceed its short term liabilities ($118.3M).
Long Term Liabilities: SLAB's short term assets ($614.1M) exceed its long term liabilities ($49.6M).
Debt to Equity History and Analysis
Debt Level: SLAB is debt free.
Reducing Debt: SLAB has no debt compared to 5 years ago when its debt to equity ratio was 33.7%.
Debt Coverage: SLAB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SLAB has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 08:52 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/28 |
| Annual Earnings | 2023/12/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Silicon Laboratories Inc. is covered by 44 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Christopher Muse | Barclays |
| Thomas O'Malley | Barclays |